S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
S&P 500   4,467.71
DOW   35,123.36
QQQ   367.91
2 Tech Stocks to Buy and One to Avoid in August
Laser breakthrough could send stock soaring 2,467% (Ad)
3 Stocks to Buy No Matter Which Way Inflation Moves
3 Stocks to Buy After Heavy Insider Buying
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
2 Alternatives To Tesla (1 Safe, 1 More Risky)
The Rivian Market Is About To Shift Into A Higher Gear 
Ben Stein FREE Report: How Americans Are RUINING Retirement (Ad)
7 Best Fintech ETFs to Buy Now
How major US stock indexes fared Wednesday, 8/9/2023
OTCMKTS:GBCS

Selectis Health (GBCS) Stock Forecast, Price & News

$5.00
+3.95 (+376.19%)
(As of 08/9/2023 ET)
Compare
Today's Range
$4.75
$6.25
50-Day Range
$1.05
$5.00
52-Week Range
$1.00
$6.99
Volume
2,100 shs
Average Volume
1,144 shs
Market Capitalization
$15.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

GBCS stock logo

About Selectis Health (OTCMKTS:GBCS) Stock

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.

GBCS Price History

GBCS Stock News Headlines

UP Health System-Bell
Wall Street Insider Makes Prediction about Hot A.I. Stock
50-year Wall Street Veteran Marc Chaikin just detailed why he's avoiding NVDA and buying this overlooked A.I. stock instead. Learn more here.
Terrebonne General Health System-Houma
Wall Street Insider Makes Prediction about Hot A.I. Stock
50-year Wall Street Veteran Marc Chaikin just detailed why he's avoiding NVDA and buying this overlooked A.I. stock instead. Learn more here.
Best Online Pharmacies Of May 2023
Best Online Dating Sites Of 2023
The Best Bug Sprays For 2023
Best Online Marriage Counseling Of 2023
Best Tablets For Seniors Of 2023
North Memorial Health Hospital
Selectis Health Reports Third Quarter 2022 Results
Future of Health
Selectis Health to Present at the LD Micro Main Event XV
See More Headlines
Receive GBCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Selectis Health and its competitors with MarketBeat's FREE daily newsletter.

GBCS Company Calendar

Last Earnings
6/29/2023
Today
8/10/2023
Next Earnings (Estimated)
9/18/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GBCS
Employees
671
Year Founded
N/A

Profitability

Net Income
$-2,400,000.00
Pretax Margin
-5.90%

Debt

Sales & Book Value

Annual Sales
$40.60 million
Book Value
$0.06 per share

Miscellaneous

Free Float
2,601,000
Market Cap
$15.35 million
Optionable
Not Optionable
Beta
0.41
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Lance Jason Baller (Age 50)
    CEO, Principal Financial Officer & Chairman
    Comp: $230k
  • Ms. Christine Lucus (Age 33)
    Company Sec.
    Comp: $138.89k
  • Ms. Sarah Day
    Director of Therapy, Marketing & Staffing













GBCS Stock - Frequently Asked Questions

How have GBCS shares performed in 2023?

Selectis Health's stock was trading at $4.74 at the start of the year. Since then, GBCS shares have increased by 5.5% and is now trading at $5.00.
View the best growth stocks for 2023 here
.

When is Selectis Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, September 18th 2023.
View our GBCS earnings forecast
.

How were Selectis Health's earnings last quarter?

Selectis Health, Inc. (OTCMKTS:GBCS) announced its quarterly earnings results on Thursday, June, 29th. The company reported ($0.72) earnings per share for the quarter. The firm had revenue of $10.80 million for the quarter. Selectis Health had a negative net margin of 4.59% and a negative trailing twelve-month return on equity of 82.67%.

When did Selectis Health's stock split?

Selectis Health's stock reverse split on Wednesday, September 22nd 2021. The 1-10 reverse split was announced on Wednesday, September 22nd 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, September 22nd 2021. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Selectis Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Selectis Health investors own include Chemed (CHE), Walt Disney (DIS), OceanFirst Financial (OCFC), Celanese (CE), Credit Acceptance (CACC), Blackstone Mortgage Trust (BXMT), Blackstone (BX), Black Hills (BKH), Sothebys (BID) and Basf (BASFY).

What is Selectis Health's stock symbol?

Selectis Health trades on the OTCMKTS under the ticker symbol "GBCS."

How do I buy shares of Selectis Health?

Shares of GBCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Selectis Health's stock price today?

One share of GBCS stock can currently be purchased for approximately $5.00.

How much money does Selectis Health make?

Selectis Health (OTCMKTS:GBCS) has a market capitalization of $15.35 million and generates $40.60 million in revenue each year. The company earns $-2,400,000.00 in net income (profit) each year or ($0.64) on an earnings per share basis.

How many employees does Selectis Health have?

The company employs 671 workers across the globe.

How can I contact Selectis Health?

Selectis Health's mailing address is 6800 N 79TH ST SUITE 200, NIWOT CO, 80503. The official website for the company is www.gbcsreit.com. The company can be reached via phone at (720) 680-0808, via email at jtaylor@gbcsreit.com, or via fax at 303-527-2916.

This page (OTCMKTS:GBCS) was last updated on 8/10/2023 by MarketBeat.com Staff

My Account -